House Committee Quizzes FDA on Complex Generic Drugs

Monday, January 20, 2020

Regulatory Focus–A bipartisan group of House Energy & Commerce Committee leaders last Friday sent a letter to US Food and Drug Administration (FDA) Commissioner Stephen Hahn seeking information on the agency’s efforts to approve complex generic drugs more quickly.